By manipulating FHL2 expression in KGN cells and COV434 cell, our data indicate that FHL2 acts as a GCT tumor cell growth-promoting factor, implying that FHL2 may function as an oncogenic protein in ovarian tumors. This evidence concerns the gene FHL2 and granular cell tumor.